Perspectives of Reprogramming Breast Cancer Metabolism
- 28 December 2017
- book chapter
- Published by Springer Nature
- Vol. 1026, 217-232
Abstract
Reprogramming of cellular metabolism is one of the hallmarks of breast cancer. Breast cancer cells remodel metabolic network to maintain their transformed state and survive in a harsh tumor microenvironment. Dysregulated metabolism further interacts with cellular signaling and epigenetics to promote breast cancer development. Meanwhile, breast cancer stem cells exhibit unique metabolic features, which are critical for therapeutic resistance and tumor recurrence. Besides, aberrant metabolism of breast cancer cells reshapes tumor microenvironment, such as promoting cancer vascularization and sabotaging tumor immunity, to accelerate tumor progression. These special metabolic traits not only open vulnerabilities of breast cancer by targeting essential metabolic pathways but also provide promising diagnostic and prognostic biomarkers to facilitate clinical investigations. Studies in the last few decades have significantly advanced our understanding of mechanisms underlying the reprogramming of breast cancer metabolism and metabolic regulation of breast cancer biology. Targeting tumor metabolism serves as a potentially effective therapeutic approach to suppress breast cancer.Keywords
This publication has 71 references indexed in Scilit:
- Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic CancerMolecular Cell, 2016
- Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast CancerCancer Research, 2016
- Cancer stem cell metabolismBreast Cancer Research, 2016
- The Emerging Hallmarks of Cancer MetabolismCell Metabolism, 2016
- Metabolic pathways promoting cancer cell survival and growthNature Cell Biology, 2015
- Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer GrowthCell Reports, 2014
- The pentose phosphate pathway and cancerTrends in Biochemical Sciences, 2014
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of CancerCancer Cell, 2013
- Global Profiling Strategies for Mapping Dysregulated Metabolic Pathways in CancerCell Metabolism, 2012
- Oncogenes and CancerNew England Journal of Medicine, 2008